NeuroPace, Inc.'s (NPCE) CEO Mike Favet on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/21
NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized EpilepsyGlobeNewsWire • 11/10/21
NeuroPace to Report Third Quarter 2021 Financial Results on November 10, 2021GlobeNewsWire • 10/20/21
NeuroPace, Inc. (NPCE) CEO Mike Favet on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/14/21
NeuroPace Launches nSight Platform and Partnership with Seizure Tracker™ to Provide Doctors With Personalized Information About Their Patients' Seizure BurdenBusiness Wire • 08/04/21
NeuroPace Awarded Five-Year NIH Grant Funding of More than $9M to Study RNS System in Patients with Lennox-Gastaut SyndromeGlobeNewsWire • 06/30/21
NeuroPace's (NPCE) CEO Mike Favet on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 06/03/21
NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial GuidanceGlobeNewsWire • 06/03/21
NeuroPace, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 04/26/21